Free Trial

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?

NorthWest Health Prop Real Est Inv Trust logo with Real Estate background

Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$4.94 and traded as high as C$5.02. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.95, with a volume of 971,901 shares.

Analyst Ratings Changes

Separately, National Bankshares lifted their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the company an "outperform" rating in a research report on Tuesday, March 11th.

Read Our Latest Report on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Stock Performance

The stock has a market cap of C$1.12 billion, a price-to-earnings ratio of -2.87, a P/E/G ratio of 0.74 and a beta of 1.05. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The stock's 50-day moving average is C$4.84 and its 200-day moving average is C$4.92.

NorthWest Health Prop Real Est Inv Trust Company Profile

(Get Free Report)

NorthWest Healthcare Properties Real Estate Investment Trust TSX: NWH.UN (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.

Read More

Should You Invest $1,000 in NorthWest Health Prop Real Est Inv Trust Right Now?

Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.

While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines